SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 23, Issue 24, Pages 6644-6658
Publisher
Oxford University Press (OUP)
Online
2014-07-16
DOI
10.1093/hmg/ddu372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEε4 Genotype
- (2017) Julius Popp et al. JOURNAL OF ALZHEIMERS DISEASE
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
- (2013) Carlos Cruchaga et al. NEURON
- Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort
- (2013) Lyzel S. Elias-Sonnenschein et al. PLoS One
- Quick, “Imputation-free” meta-analysis with proxy-SNPs
- (2012) Christian Meesters et al. BMC BIOINFORMATICS
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
- (2012) Michael T. Heneka et al. NATURE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The Role of Clusterin, Complement Receptor 1, and Phosphatidylinositol Binding Clathrin Assembly Protein in Alzheimer Disease Risk and Cerebrospinal Fluid Biomarker Levels
- (2011) Brit-Maren M. Schjeide et al. ARCHIVES OF GENERAL PSYCHIATRY
- The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion
- (2011) Chaya Miller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Prediction of Dementia in Primary Care Patients
- (2011) Frank Jessen et al. PLoS One
- Genome-wide association reveals genetic effects on human Aβ 42 and τ protein levels in cerebrospinal fluids: a case control study
- (2010) Mi-Ryung Han et al. BMC Neurology
- Neuroprotective strategies involving ROS in Alzheimer disease
- (2010) Magali Dumont et al. FREE RADICAL BIOLOGY AND MEDICINE
- The role of microglia in amyloid clearance from the AD brain
- (2010) C. Y. Daniel Lee et al. JOURNAL OF NEURAL TRANSMISSION
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease
- (2010) Brandy L. Wilkinson et al. NEUROBIOLOGY OF AGING
- Genome-wide association study of CSF biomarkers A 1-42, t-tau, and p-tau181p in the ADNI cohort
- (2010) S. Kim et al. NEUROLOGY
- Biomarkers in translational research of Alzheimer’s Disease
- (2010) Rawan Tarawneh et al. NEUROPHARMACOLOGY
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- INTERSNP: genome-wide interaction analysis guided by a priori information
- (2009) C. Herold et al. BIOINFORMATICS
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment
- (2009) Johannes Kornhuber et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Microglia Mediate the Clearance of Soluble A through Fluid Phase Macropinocytosis
- (2009) S. Mandrekar et al. JOURNAL OF NEUROSCIENCE
- Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate
- (2009) Elisabeth Mangold et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
- (2009) Bryan N. Howie et al. PLoS Genetics
- Practical aspects of imputation-driven meta-analysis of genome-wide association studies
- (2008) P. I.W. de Bakker et al. HUMAN MOLECULAR GENETICS
- Disorders caused by deficiency of succinate-CoA ligase
- (2008) E. Ostergaard JOURNAL OF INHERITED METABOLIC DISEASE
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started